BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10619441)

  • 1. Expression of ACE mRNA in the human atrial myocardium is not dependent on left ventricular function, ACE inhibitor therapy, or the ACE I/D genotype.
    Spruth E; Zurbrügg HR; Warnecke C; Erdmann J; Pregla R; Pfautsch P; Hetzer R; Fleck E; Regitz-Zagrosek V
    J Mol Med (Berl); 1999 Nov; 77(11):804-10. PubMed ID: 10619441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/deletion polymorphism and left ventricular function.
    Davis GK; Millner RW; Roberts DH
    Eur J Heart Fail; 2000 Sep; 2(3):253-6. PubMed ID: 10938484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy.
    Candy GP; Skudicky D; Mueller UK; Woodiwiss AJ; Sliwa K; Luker F; Esser J; Sareli P; Norton GR
    Am J Cardiol; 1999 Mar; 83(5):740-4. PubMed ID: 10080429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
    Batlle M; Roig E; Perez-Villa F; Lario S; Cejudo-Martin P; García-Pras E; Ortiz J; Roqué M; Orús J; Rigol M; Heras M; Ramírez J; Jimenez W
    J Heart Lung Transplant; 2006 Sep; 25(9):1117-25. PubMed ID: 16962475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACE gene polymorphism correlation (I/D) with the ventricular function in patients with ischemic and idiopathic dilated cardiomyopathy].
    Avila-Vanzzini N; Espínola-Zavaleta N; Masso-Rojas F; Varela-López E; Casanova-Garcés JM; Kury-Alfaro J; Herrera-Bello H
    Rev Invest Clin; 2006; 58(1):39-46. PubMed ID: 16789598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
    Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
    J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
    Kobayashi N; Hara K; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism.
    Contini M; Compagnino E; Cattadori G; Magrì D; Camera M; Apostolo A; Farina S; Palermo P; Gertow K; Tremoli E; Fiorentini C; Agostoni P
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):159-68. PubMed ID: 26847573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.
    Bukowska A; Spiller L; Wolke C; Lendeckel U; Weinert S; Hoffmann J; Bornfleth P; Kutschka I; Gardemann A; Isermann B; Goette A
    Exp Biol Med (Maywood); 2017 Aug; 242(14):1412-1423. PubMed ID: 28661206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure.
    Morawietz H; Szibor M; Goettsch W; Bartling B; Barton M; Shaw S; Koerfer R; Zerkowski HR; Holtz J
    Circulation; 2000 Nov; 102(19 Suppl 3):III188-93. PubMed ID: 11082385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart.
    Bánhegyi V; Enyedi A; Fülöp GÁ; Oláh A; Siket IM; Váradi C; Bottyán K; Lódi M; Csongrádi A; Umar AJ; Fagyas M; Czuriga D; Édes I; Pólos M; Merkely B; Csanádi Z; Papp Z; Szabó G; Radovits T; Takács I; Tóth A
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359878
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.
    Danser AH; Schalekamp MA; Bax WA; van den Brink AM; Saxena PR; Riegger GA; Schunkert H
    Circulation; 1995 Sep; 92(6):1387-8. PubMed ID: 7664416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic ACE I/D polymorphism and recurrence of atrial fibrillation after catheter ablation.
    Ueberham L; Bollmann A; Shoemaker MB; Arya A; Adams V; Hindricks G; Husser D
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):732-7. PubMed ID: 23876437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.